Stability of serial platelet and urine protein measurements in patients receiving nusinersen for spinal muscular atrophy

INTRODUCTION/AIMS: Patients undergoing nusinersen treatment for spinal muscular atrophy are subject to measurements of platelet count and urine protein before each injection due to concern for platelet depletion and renal dysfunction according to the prescribing information. These tests may be uncom...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagarajan, Eric K., Özütemiz, Can, Rubin, Nathan, Nascene, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Clinical Research Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321971/
https://www.ncbi.nlm.nih.gov/pubmed/35466424
http://dx.doi.org/10.1002/mus.27564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321971/
https://www.ncbi.nlm.nih.gov/pubmed/35466424
http://dx.doi.org/10.1002/mus.27564

Ejemplares similares